Search

everythinglearnresearchcommunity

for

Search:↓

Bone marrow and hair follicle cells help form skin tumors, suggesting new treatment targets.

Radiation damages hair stem cells and changes keratin expression, with Krt5 as a potential marker for radiation effects.

Genomic profiling for myeloid cancers can find important inherited mutations, but it's challenging when these mutations aren't related to the patient's symptoms.

Platelet-rich fibrin may help reduce nonmelanoma skin cancer cell growth.

Neuroendocrine paraneoplastic syndromes often show skin changes, helping early diagnosis and requiring a team approach for best care.

Gefitinib treatment led to unexpected hair growth in two lung cancer patients.

Wound healing can help prevent hair loss from chemotherapy in young rats by increasing interleukin-1β signaling.

A 7-year-old girl experienced temporary hair loss due to radiation, with signs of possible hair regrowth.

The case shows the importance of quick and thorough evaluation of adrenal tumors to prevent rapid disease progression and poor outcomes.

Some drugs may help treat both COVID-19 and radiation injury.

A man developed a rare cancer on his scalp after a hair transplant possibly due to sun damage, laser effects, and inflammation.

Chemotherapy with carboplatin-paclitaxel causes hair loss in all patients.

Abnormal activation of hair follicle stem cells and Wnt/β-catenin signaling contributes to sebaceous neoplasms.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

EGFR deficiency in skin causes hair follicle issues and inflammation.

A new genetic region, 17q21.31, is linked to higher ovarian cancer risk.

Prostaglandins may protect hair follicles during chemotherapy.

Vitamin D may help protect against nonmelanoma skin cancer.

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

Cancer patients, especially with blood cancers, face severe COVID-19 risks due to weakened immunity.

Minor skin injuries can boost hair growth by increasing TNF-α.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

Increased ornithine decarboxylase makes normally tumor-resistant mice more sensitive to tumors.

UV exposure harms skin by causing fibroblast loss, but T cells help fibroblast survival.

Certain chemotherapy drugs can cause permanent hair loss in stem cell transplant patients.

A new treatment may prevent hair loss from chemotherapy by normalizing scalp cell death and reducing inflammation.

Overexpression of PKCepsilon leads to increased TNFalpha, promoting metastatic squamous cell carcinoma in mice.

Endocrine therapies for cancer significantly increase the risk of hair loss.